Targeted lung cancer therapy
Transplanted kidney structure and function improved with sirolimus-based therapy
Swedish approval granted for valsartan in the treatment of high-risk heart attack patients
Tysabri® approved for treatment of multiple sclerosis
Prialt™ gains European recommendation for the intrathecal treatment of severe chronic pain
Study results show dramatic decrease in reports of cardiovascular disease events in patients with diabetes
Combunox™ receives approval for the treatment of short term acute, moderate-to-severe pain
Tacrolimus most effective topical calcineurin inhibitor for eczema therapy
Possible link found between SSRI use and abnormal bleeding
Treatment-related risks of cancer therapy have dropped over the last 10 years
Adalimumab for the treatment of rheumatoid arthritis
Pimecrolimus for the treatment of atopic dermatitis
The changing role of thrombolytic therapy in the management of acute deep vein thrombosis
Mutant prevention concentration as a strategy to minimize antimicrobial resistance
Adjunct antimicrobial therapy – prospects for the future
Purine and nonpurine pharmacological cyclin-dependent kinase inhibitors target initiation of viral transcription
Experience with refractory vitamin D-resistant rickets and non-17α alkyl testosterone derivative anabolic agent
Two-hour post-dose cyclosporine monitoring does not fit all in kidney transplantation
Short-term difference in mood with sibutramine versus placebo in obese patients with and without depression
An overview of the beneficial cardiovascular effects of thiazolidinediones
Stromal cells as new therapeutic targets in rheumatoid arthritis
HIV-1 virulence, fitness and replication capacity
The anandamide membrane transporter and the therapeutic implications of its inhibition